Thijs Oude Munnink

11PUBLICATIONS
58CO-AUTHORS
Environmental assessment and monitoringPharmacogenomicsRegenerative medicine (incl. stem cells)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 17, 2026
Towards appropriate guidance for the ethical challenges of environmentally sustainable prescribing.

|Jul 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitors.

|Mar 10, 2026
Ribavirin for Paramyxovirus Infections in Hematopoietic Stem-Cell Transplant and Lung Transplant Recipients: Evaluation of an Optimized Dosing Regimen.

Manon C Wilpshaar, Berdien Oortgiesen, Martijn Bakker

|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries, Eric J F Franssen, Arthur A J Smit

|Apr 27, 2025
Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations.

Simone D Baan, Daan J Touw, Marjolijn N Lub-de Hooge

|Jun 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Dirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar

Pageof 2

Frequent Collaborators

2 joint publications

Rob Ter Heine

2 joint publications

Michel M van den Heuvel

2 joint publications

Jeroen J M A Hendrikx

2 joint publications

Dirk Jan A R Moes